Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recombinant Alpha-1 Antitrypsin-Fc Fusion Protein INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency: A Phase 1 Study.
Brantly ML, Kuhn BT, Farah HW, Mahadeva R, Cole A, Chang CL, Brown CD, Campos MA, Lascano JE, Babcock EK, Bhagwat SP, Boyea TF, Veldstra CA, Andrianov V, Kalabus JL, Eckelman BP, Veale AG. Brantly ML, et al. Among authors: andrianov v. Chronic Obstr Pulm Dis. 2024 May 29;11(3):282-292. doi: 10.15326/jcopdf.2023.0469. Chronic Obstr Pulm Dis. 2024. PMID: 38809792 Free PMC article.
Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma.
Subbiah V, Chawla SP, Conley AP, Wilky BA, Tolcher A, Lakhani NJ, Berz D, Andrianov V, Crago W, Holcomb M, Hussain A, Veldstra C, Kalabus J, O'Neill B, Senne L, Rowell E, Heidt AB, Willis KM, Eckelman BP. Subbiah V, et al. Among authors: andrianov v. Clin Cancer Res. 2023 Aug 15;29(16):2988-3003. doi: 10.1158/1078-0432.CCR-23-0974. Clin Cancer Res. 2023. PMID: 37265425 Free PMC article. Clinical Trial.
Investigation of NO Role in Neural Tissue in Brain and Spinal Cord Injury.
Andrianov VV, Kulchitsky VA, Yafarova GG, Bazan LV, Bogodvid TK, Deryabina IB, Muranova LN, Silantyeva DI, Arslanov AI, Paveliev MN, Fedorova EV, Filipovich TA, Nagibov AV, Gainutdinov KL. Andrianov VV, et al. Molecules. 2023 Oct 31;28(21):7359. doi: 10.3390/molecules28217359. Molecules. 2023. PMID: 37959778 Free PMC article.
Aromatic sulphonamides of aziridine-2-carboxylic acid derivatives as novel PDIA1 and PDIA3 inhibitors.
Zelencova-Gopejenko D, Andrianov V, Domracheva I, Kanepe-Lapsa I, Milczarek M, Stojak M, Przyborowski K, Fedak FA, Walczak M, Kramkowski K, Wietrzyk J, Chlopicki S, Kalvins I. Zelencova-Gopejenko D, et al. Among authors: andrianov v. J Enzyme Inhib Med Chem. 2023 Dec;38(1):2158187. doi: 10.1080/14756366.2022.2158187. J Enzyme Inhib Med Chem. 2023. PMID: 37070480 Free PMC article.
Exploring Aspartic Protease Inhibitor Binding to Design Selective Antimalarials.
Bobrovs R, Basens EE, Drunka L, Kanepe I, Matisone S, Velins KK, Andrianov V, Leitis G, Zelencova-Gopejenko D, Rasina D, Jirgensons A, Jaudzems K. Bobrovs R, et al. Among authors: andrianov v. J Chem Inf Model. 2022 Jul 11;62(13):3263-3273. doi: 10.1021/acs.jcim.2c00422. Epub 2022 Jun 17. J Chem Inf Model. 2022. PMID: 35712895
282 results